Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (1) , 504-513
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital (CMRPG8E1642)
This publication has 26 references indexed in Scilit:
- Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapyJournal of Gastroenterology, 2011
- Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinomaInternational Journal of Clinical Oncology, 2010
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experienceJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- FIB-4Hepatology, 2007
- Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective studyHepatology, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyCancer, 2004
- Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinomaCancer, 2003
- Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosisJournal of Gastroenterology, 2003